Related Experiment Video
Updated: Jul 18, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
Mycophenolate mofetil treatment improves hypertension in patients with psoriasis and rheumatoid arthritis
Jose Herrera1, Atilio Ferrebuz, Ernesto García MacGregor
1Renal Service, Hospital Universitario, Universidad del Zulia, Maracaibo, Estado Zulia, Venezuela.
Abstract:
Evidence that was obtained in several experimental models and in strains of hypertensive rats indicates that infiltration of inflammatory cells and oxidative stress in the kidney play a role in the induction and maintenance of hypertension. Similar evidence is lacking in human hypertension, at least in part, because immunosuppressive treatment is unjustified in patients with hypertension. For addressing this issue, patients who were prescribed by their private physicians mycophenolate mofetil (MMF) for the treatment of psoriasis or rheumatoid arthritis and had, in addition, grade I essential hypertension and normal renal function were studied. Eight patients were studied before MMF was started, during MMF treatment, and 1 mo after MMF treatment had been discontinued. Other treatments and diet were unchanged in the three phases of the study. MMF therapy was associated with a significant reduction in systolic, diastolic, and mean BP. Urinary excretion of TNF-alpha was reduced progressively by MMF treatment and increased after MMF was discontinued. Reduction of urinary malondialdehyde, TNF-alpha, and RANTES excretion during MMF administration did not reach statistical significance but had a direct positive correlation with the BP levels. These data are consistent with the hypothesis that renal immune cell infiltration and oxidative stress play a role in human hypertension.
Insights
Mycophenolate mofetil (MMF) significantly reduced blood pressure in hypertensive patients. This suggests that kidney inflammation and oxidative stress contribute to human hypertension, offering potential therapeutic insights.
Area of Science:
- Nephrology
- Immunology
- Cardiovascular Medicine
Background:
- Experimental models suggest kidney inflammation and oxidative stress contribute to hypertension.
- Human studies are limited due to the unsuitability of immunosuppressive treatments for hypertension.
Purpose of the Study:
- To investigate the role of renal immune cell infiltration and oxidative stress in human hypertension.
- To assess the effect of mycophenolate mofetil (MMF) on blood pressure and related biomarkers in hypertensive patients.
Main Methods:
- Studied eight patients with essential hypertension and normal renal function, prescribed MMF for other conditions.
- Monitored blood pressure and urinary biomarkers (TNF-alpha, malondialdehyde, RANTES) during three phases: before, during, and after MMF treatment.
- Maintained consistent diet and other treatments throughout the study.
Main Results:
- MMF therapy significantly reduced systolic, diastolic, and mean blood pressure.
- Urinary TNF-alpha excretion decreased during MMF treatment and increased upon discontinuation.
- Reductions in urinary malondialdehyde and RANTES showed a positive correlation with blood pressure levels.
Conclusions:
- MMF treatment effectively lowered blood pressure in patients with essential hypertension.
- Findings support the hypothesis that renal immune cell infiltration and oxidative stress are implicated in human hypertension.
- Suggests a potential therapeutic role for targeting inflammation and oxidative stress in managing hypertension.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Rheumatic Heart Disease III: Medical Management
Hypertension IV: Drug Therapy and Lifestyle Modifications
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids